SCHEMBL2157797

SCHEMBL2157797

C=Cc1ccccc1-c1[nH]c2cc(C(=O)OC)sc2c1-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.37
ALDH1A1 P00352 8/20 0.37
HPGD P15428 4/20 0.37
KDM4E B2RXH2 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
RAB9A P51151 1/20 0.37
GAA P10253 2/20 0.36
GLA P06280 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
ATM Q13315 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
C1S P09871 1/20 0.35
NR4A2 P43354 1/20 0.34
MAPT P10636 3/20 0.34
PAK4 O96013 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2156447 0.85 RAF1 (0.40) LMNAALDH1A1HPGDKDM4EL3MBTL1
SCHEMBL2987902 0.84 LMNA (0.45) LMNAALDH1A1HPGDKDM4EL3MBTL1
SCHEMBL2868302 0.84 ALDH1A1 (0.40) LMNAALDH1A1HPGDKDM4EL3MBTL1
SCHEMBL2157791 0.80 KDM4E (0.39) ALDH1A1HPGDKDM4EL3MBTL1RAB9A
SCHEMBL2986582 0.78 PTGS2 (0.42) LMNAALDH1A1HPGDKDM4ERAB9A
SCHEMBL2859156 0.78 ALDH1A1 (0.38) LMNAALDH1A1KDM4EL3MBTL1RAB9A
SCHEMBL2156359 0.76 LMNA (0.44) LMNAALDH1A1HPGDKDM4EL3MBTL1
SCHEMBL2156283 0.75 PTPN1 (0.37) ALDH1A1HPGDKDM4EL3MBTL1GAA
SCHEMBL2156338 0.74 ALDH1A1 (0.41) LMNAALDH1A1HPGDKDM4EL3MBTL1
SCHEMBL2860807 0.74 CSNK2A2 (0.40) ALDH1A1HPGDKDM4ETSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973026-B2 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-07-05 US disclosed
US-20090105227-A1 Thienopyrroles As Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-04-23 US disclosed
EP-1881989-A1 THIENOPYRROLES AS ANTIVIRAL AGENTS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2008-01-30 EP disclosed
WO-2006119975-A1 THIENOPYRROLES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2006-11-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105227-A1 Thienopyrroles As Antiviral Agents ZC3HAV1, HAVCR2, ZC3HAV1L LMNA 4377/4885ALDH1A1 433/4885HPGD 1422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.